Bourgeon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bourgeon Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20	Closed	-$10.6K	–	353
2023 Q4	$10.6K	Hold	20	–	–	﹤0.01%	238
2023 Q3	$10.1K	Hold	20	–	–	﹤0.01%	235
2023 Q2	$10.4K	Hold	20	–	–	﹤0.01%	250
2023 Q1	$11.5K	Hold	20	–	–	﹤0.01%	226
2022 Q4	$11K	Hold	20	–	–	﹤0.01%	234
2022 Q3	$10K	Hold	20	–	–	﹤0.01%	220
2022 Q2	$11K	Hold	20	–	–	﹤0.01%	219
2022 Q1	$12K	Hold	20	–	–	﹤0.01%	225
2021 Q4	$13K	Hold	20	–	–	﹤0.01%	209
2021 Q3	$11K	Hold	20	–	–	﹤0.01%	226
2021 Q2	$10K	Hold	20	–	–	﹤0.01%	232
2021 Q1	$9K	Hold	20	–	–	﹤0.01%	232
2020 Q4	$9K	Hold	20	–	–	﹤0.01%	221
2020 Q3	$9K	Hold	20	–	–	﹤0.01%	222
2020 Q2	$7K	Hold	20	–	–	﹤0.01%	207
2020 Q1	$6K	Hold	20	–	–	﹤0.01%	205
2019 Q4	$6K	Hold	20	–	–	﹤0.01%	204
2019 Q3	$6K	Buy	+20	New	+$5.73K	﹤0.01%	198

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bourgeon Capital Management's TMO Position: Q1 2024 in Review

Bourgeon Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 20 shares — an estimated $10.6K sold.

Bourgeon Capital Management first reported a position in TMO in Q3 2019 and held it in 18 quarters. The position peaked at $13K in Q4 2021. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Bourgeon Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
Bourgeon Capital Management sold 20 Thermo Fisher Scientific shares in Q1 2024, an estimated $10.6K.
Bourgeon Capital Management first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 18 quarters.
Bourgeon Capital Management's Thermo Fisher Scientific position peaked at $13K in Q4 2021.
2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Bourgeon Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.